ReviewAnnals of nuclear medicine2019
4-Borono-2-
Review in Annals of nuclear medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 63 citations in OpenAlex.
- Automated radiosynthesis of 2-[EJNMMI radiopharmacy and chemistry · 2026Article
- Review
- State-of-the-art boron clusters for boron neutron-capture therapy.Theranostics · 2026Review
- Hypo-segmentation ofEJNMMI research · 2025Article
- Pharmacokinetics study of FT-FAPI, a novel multi-nuclide label-able FAP targeting tracer, in mice and healthy volunteers.European journal of nuclear medicine and molecular imaging · 2025Article
- Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control.Advances in radiation oncology · 2025Article
- Prompt gamma-ray imaging in realistic background conditions of a boron neutron capture therapy facility.Scientific reports · 2025Article
- LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals.Theranostics · 2025Review
- Prognostic assessment ofQuantitative imaging in medicine and surgery · 2024Article
- PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy.Pharmaceuticals (Basel, Switzerland) · 2024Article
- A compact scintillator-based detector with collimator and shielding for dose monitoring in boron neutron capture therapy.Physics and imaging in radiation oncology · 2024Article
- Correcting for the heterogeneous boron distribution in a tumor for BNCT dose calculation.Scientific reports · 2023Article
- Investigation of the Impact of L-Phenylalanine and L-Tyrosine Pre-Treatment on the Uptake of 4-Borono-L-Phenylalanine in Cancerous and Normal Cells Using an Analytical Approach Based on SC-ICP-MS.Molecules (Basel, Switzerland) · 2023Article
- Development of a 2-(2-Hydroxyphenyl)-1Cancers · 2023Article
- Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma.International journal of molecular sciences · 2023Article
- Recent Development of Radiofluorination of Boron Agents for Boron Neutron Capture Therapy of Tumor: Creation ofPharmaceuticals (Basel, Switzerland) · 2023Review
- Analyzing spatial distribution betweenEJNMMI physics · 2022Article
- Exploration of the threshold SUV for diagnosis of malignancy usingEuropean journal of hybrid imaging · 2022Article
- Boron Neutron Capture Therapy: Clinical Application and Research Progress.Current oncology (Toronto, Ont.) · 2022Review
- Development of Brain-Tumor-Targeted Benzothiazole-Based Boron Complex for Boron Neutron Capture Therapy.ACS medicinal chemistry letters · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
4-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.